New sickle cell treatment given to first patients in England
Crizanlizumab is thought to cut visits to A&E by 40% for patients with the blood disorder.Crizanlizumab is thought to cut visits to A&E by 40% for patients with the blood disorder.Crizanlizumab is thought to cut visits to A&E by 40% for patients with the blood disorder.External Content
| Source | RSS or Atom Feed |
| Feed Location | http://feeds.bbci.co.uk/news/health/rss.xml |
| Feed Title | BBC News |
| Feed Link | https://www.bbc.co.uk/news/health |
| Feed Copyright | Copyright: (C) British Broadcasting Corporation, see https://www.bbc.co.uk/usingthebbc/terms-of-use/#15metadataandrssfeeds for terms and conditions of reuse. |
| Reply | 0 comments |